SUTOL Bio

SUTOL Bio is a Cambridge, MA biotechnology startup spun out of six years of translational research in the Langer and Traverso laboratories at MIT. It is developing a self-assembling, gastric-resident oral capsule platform - the first gram-scale monthly oral capsule - that releases medication continuously for 30+ days from a single monthly dose, targeting adherence-critical conditions including HIV, schizophrenia, opioid use disorder and bipolar disorder, alongside a companion-animal program in atopic dermatitis. Co-founded by CEO Seungho Lee, the company is a resident at The Engine incubator in Cambridge and reports support from the Gates Foundation; Robert Langer and Giovanni Traverso serve as co-founders and scientific advisors.

  • Seed
  • Biotechnology
  • Healthtech
  • Mental Health
  • Healthcare & Life Sciences

1

Round

1

Industry

4

Tags

Nov 10, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 10, 2026

    $474,000

    Seed

    Article coming soon.

Pricing

Research SUTOL Bio — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if SUTOL Bio is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational